2021 Medtrade East

Sessions Speakers Exhibitors Products Press Releases Show Specials Floor Plan Buzz

The Impact of Compliance on Company Valuations (Room C205)

18 Oct 21
2:45 PM - 4:15 PM

Tracks: Executive Leadership and Planning

The HME industry has seen significant consolidation over the past several years. In today's environment, investors and suppliers interested in purchasing your business are no longer willing to take on significant risk. As part of the due diligence process, they are performing claim audits and compliance assessments that often result in errors or issues being identified that could negatively impact the valuation of your company and in the worst of cases, put the whole deal in jeopardy. Investors make compliance a determining factor in their valuations. In today's environment, they often try to mitigate the risk as much as possible in the transaction, including escrow accounts to cover compliance risk or requalification processes that impact pay-outs. However, having a comprehensive compliance process will help protect your organization in the event of a transaction. This presentation will discuss the due diligence process and what steps your organization can implement operationally to prepare from the several unique points of view in the due diligence process.